Detalles de la búsqueda
1.
Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).
Br J Haematol
; 175(5): 917-924, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27714772
Resultados
1 -
1
de 1
1
Próxima >
>>